GSA Capital Partners’s Elanco Animal Health ELAN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-47,477
| Closed | -$499K | – | 1838 |
|
|
2025
Q1 | $499K | Sell |
47,477
-7,015
| -13% | -$73.7K | 0.05% | 805 |
|
|
2024
Q4 | $660K | Buy |
54,492
+23,500
| +76% | +$285K | 0.05% | 703 |
|
|
2024
Q3 | $455K | Sell |
30,992
-18,375
| -37% | -$270K | 0.03% | 967 |
|
|
2024
Q2 | $712K | Buy |
49,367
+16,519
| +50% | +$238K | 0.05% | 739 |
|
|
2024
Q1 | $535K | Buy |
+32,848
| New | +$535K | 0.04% | 838 |
|
|
2023
Q4 | – | Sell |
-21,508
| Closed | -$242K | – | 1598 |
|
|
2023
Q3 | $242K | Sell |
21,508
-34,866
| -62% | -$392K | 0.02% | 1197 |
|
|
2023
Q2 | $567K | Sell |
56,374
-110,024
| -66% | -$1.11M | 0.06% | 662 |
|
|
2023
Q1 | $1.56M | Buy |
166,398
+130,931
| +369% | +$1.23M | 0.15% | 132 |
|
|
2022
Q4 | $433K | Sell |
35,467
-19,059
| -35% | -$233K | 0.05% | 695 |
|
|
2022
Q3 | $677K | Buy |
54,526
+29,923
| +122% | +$372K | 0.09% | 358 |
|
|
2022
Q2 | $483K | Buy |
24,603
+10,607
| +76% | +$208K | 0.07% | 527 |
|
|
2022
Q1 | $365K | Buy |
13,996
+3,587
| +34% | +$93.5K | 0.05% | 752 |
|
|
2021
Q4 | $295K | Buy |
+10,409
| New | +$295K | 0.04% | 941 |
|
|
2019
Q4 | – | Sell |
-29,635
| Closed | -$788K | – | 1497 |
|
|
2019
Q3 | $788K | Buy |
+29,635
| New | +$788K | 0.11% | 271 |
|
|
2018
Q4 | – | Sell |
-14,000
| Closed | -$488K | – | 1435 |
|
|
2018
Q3 | $488K | Buy |
+14,000
| New | +$488K | 0.03% | 1092 |
|